UID 012304220066 Time of Registration 29/Jun/2023

Mrs. JYOTSNA GANDHI 53

Name/Age/Sex Time of Collection 29/Jun/2023 11:20AM
YRS/FEMALE
Treating Dr. Dr. SELF Report Date 29/Jun/2023

HAEMATOLOGY
Test Name Result Unit Ref. Range
Hb A1C 7.50 % Less than 5.7 %
Mean Blood Glucose 169.00 mg/dL

Comments:

The hemoglobin A1c test also called HBA1c, glycated hemoglobin test or glycohemoglobin - is the important test for assessment of long
term glucose control (also called Glycemic control) and is a better indication of long term glycemic control as than blood glucose
determination. Hemoglobin A1c provides an average of your blood sugar conrol over a six to twelve week period. people with diabetes
should have this test every three months to determine whether their blood sugars have reached the target level of control.

Result A1C

Normal Less than 5.7 %

Prediabetes 5.7 % to 6.4 %

Diabetes 6.5 % or higher

Page 1 of 5
UID 012304220066 Time of Registration 29/Jun/2023
Mrs. JYOTSNA GANDHI 53
Name/Age/Sex Time of Collection 29/Jun/2023 11:20AM
YRS/FEMALE
Treating Dr. Dr. SELF Report Date 29/Jun/2023

Test Name Result Unit Ref. Range

BIOCHEMISTRY
BLOOD GLUCOSE FASTING
BLOOD SUGAR FASTING 138.80 mg/dL 74-109
Method: Hexokinase

Page 2 of 5
UID 012304220066 Time of Registration 29/Jun/2023
Mrs. JYOTSNA GANDHI 53
Name/Age/Sex Time of Collection 29/Jun/2023 11:20AM
YRS/FEMALE
Treating Dr. Dr. SELF Report Date 29/Jun/2023

Test Name Result Unit Ref. Range

LFT,LIVER FUNCTION TEST
TOTAL BILIRUBIN 0.51 mg/dL 0.0-2.0
CONJUGATED BILIRUBIN 0.25 mg/dL 0.0-0. 2
UNCONJUGATED BILIRUBIN(INDIRECT) 0.26 mg/dL
SGOT (AST) 30.10 U/L 0-35
SGPT (ALT) 27.80 U/L 0-45
TOTAL PROTEIN 7.34 g/dL 6.4-8.3
Method: Biuret Gen 2 monochromatic

ALBUMIN,SERUM 4.46 g/dL 3.5-5.2

Method: BCG

GLOBULIN 2.88 gm/dL 2.1-3.5

A/G Ratio 1.55 1.6-2.0
ALKALINE PHOSPHATASE 83.0 U/L 53-128
COMMENTS:
Liver panel test results are not diagnostic of a specific condition. In a person who does not have symptoms or identifiable risk factors, abnormal liver test results may indicate a
temporary liver injury or reflect something that is happening elsewhere in the body - such as in the skeletal muscles, pancreas, or heart. It may also indicate early liver
disease and the need for further testing and/or periodic monitoring.
Results of liver panels are usually evaluated together. Several sets of results from tests performed over a few days or weeks are often assessed together to determine if a pattern is
present. Each person will have a unique set of test results that will typically change over time. The combination of liver test results is evaluated to gain clues about the
underlying condition.
Often, further testing is necessary to determine what is causing the liver damage and/or disease. Depending on the results of the liver panel and other factors such as signs
symptoms and clinical and family history, following tests are ordered for specific diagnosis.

Suspected type of liver disorder Other or follow-up tests

Viral infection Hepatitis A, B, C, or E

Alcohol abuse/hepatitis GGT, Ethanol

Autoimmune ANA, ASMA

Chronic Liver biopsy

Liver cancer AFP, DCP

Page 3 of 5
UID 012304220066 Time of Registration 29/Jun/2023
Mrs. JYOTSNA GANDHI 53
Name/Age/Sex Time of Collection 29/Jun/2023 11:20AM
YRS/FEMALE
Treating Dr. Dr. SELF Report Date 29/Jun/2023

Test Name Result Unit Ref. Range

KFT, KIDNEY FUNCTION TEST
BLOOD UREA 24.50 mg/dL 16.6-45.0
Serum
CREATININE,SERUM 0.93 mg/dL 0.7-1.3
Serum
URIC ACID 6.80 mg/dL 3.5-7.2
Serum
BLOOD UREA NITROGEN 11.45 mg/dL 6 .0-20.0
Serum
SODIUM, 139.00 mmol/L 135-145
Serum
POTASSIUM 4.0 mmol/L 3.5-5.5
Serum
CHLORIDE 106.00 mmol/L
Serum
CALCIUM 9.30 mg/dL 8.6-10.2

COMMENTS:

Increased urea & creatinine levels in the blood suggest diseases or conditions that affect kidney function. These can include:

Dam age to or swelling of blood vessels in the kidneys (glomerulonephritis) caused by, for example, infection or autoimmune diseases

Bacterial infection of the kidneys (pyelonephritis), prostate disease, kidney stone, or other causes of urinary tract obstruction

Death of cells in the kidneys' small tubes (acute tubular necrosis) caused by, for example, drugs or toxins

Reduced blood flow to the kidney due to shock, dehydration, congestive heart failure, atherosclerosis, or complications of diabetes

NOTE:

BUN concentrations may be elevated when there is excessive protein catabolism increased protein in diet, or gastrointestinal bleeding.

Creatinine blood levels can also increase temporarily as a result of muscle injury and are generally slightly lower during pregnancy.

Low blood levels of BUN and creatinine are not comm on, but they are also not usually a cause for concern.

Page 4 of 5
UID 012304220066 Time of Registration 29/Jun/2023
Mrs. JYOTSNA GANDHI 53
Name/Age/Sex Time of Collection 29/Jun/2023 11:20AM
YRS/FEMALE
Treating Dr. Dr. SELF Report Date 29/Jun/2023

Test Name Result Unit Ref. Range

LIPID PROFILE
CHOLESTEROL 269.0 mg/dL < 200.0
TRIGLYCERIDE 232.60 mg/dL <150.0
HDL-CHOLESTEROL 51.30 mg/dL >40.0
LDL CHOLESTEROL 171.18 mg/dl 40-130
VLDL 46.52 mg/dL 0.0-30.0
LDL / HDL RATIO 3.34 0.0-3.55
TOTAL CHOLESTEROL /HDL RATIO 5.24 0.0-4.5

Comments

Triglyceride levels > 250mg/dL are associated with an approximately 2-fold greater risk of coronary vascular disease.
Elevation of triglycerides can be seen with obesity, medication, fasting less than 12 hrs, alcohol intake & diabetes
mellitus.

Cholesterol, its fractions and triglycerides are the important plasma lipids in defining cardiovascular risk factors and in the
managment of cardiovascular disease. Values above 220 mg/dl are associated with increased risk of CHD regardless of
HDL & LDL values.
HDL-Cholesterol level <35 mg/dL is associated with an increased risk of coronary vascular disease even in the face of
desirable levels of cholesterol and LDL - cholesterol.
LDL - Cholesterol & Total Cholesterol levels can be strikingly altered by thyroid, renal and liver disease as well as
hereditary factors. There are three risk categories :-

CHOLESTEROL LDL-CHOLESTEROL CHOL/HDL RATIO

Acceptable/Low Risk < 200 mg/dL <130 mg/dL < 4.5
Borderline High Risk 200-239 mg/dL 130-159 mg/dl 4.5 - 6.0
High Risk > 240 mg /dL > 160 mg/dL > 6.0

*** End Of Report ***

Page 5 of 5